IFNGR1 and melanoma: A recent genome-wide CRISPR screen in mouse B16-F10 melanoma cells revealed a similar role of the IFNGR-JAK-STAT pathway and upregulation of MHC class I in protecting tumor cells from killing by mouse NK cells (27), indicating that this negative feedback might be a universal mechanism for tumor immune evasion.